We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Growth in Billed Business Aid AmEx (AXP) Q3 Earnings?
Read MoreHide Full Article
American Express Co. (AXP - Free Report) third-quarter 2018 results are anticipated to witness an increase in worldwide billed business across its diverse customer segments and geographies. Billed business includes activities (including cash advances) related to proprietary cards, cards issued under network partnership agreements (non-proprietary billed business), corporate payments and certain insurance fees charged on proprietary cards.
Card billed business is categorized under the United States or outside the United States based on where the Card Member is domiciled.
U.S. proprietary consumer and international proprietary consumer billings growth are likely to remain strong. the company’s U.S Platinum franchise is anticipated to drive growth in billed business.
Global Network Services billed business is expected to grow at a slower rate over the year than the proprietary business owing to the impact of the evolving regulatory environment in Europe and Australia.
Within the billed business in the U.S., categories such as proprietary consumer and commercial billed business, travel and expenditure (T&E) and non-T&E billed business, and airline related billed business are anticipated to witness growth.
Outside the U.S. billed business is expected to witness growth in Japan, Asia and Australia, Latin America and Canada, Europe, the Middle East and Africa.
In the first half of 2018, card billed business grew 1% year over year to $580.3 billion. Per the Zacks Consensus Estimate, card billed business revenue is expected to be $296 billion, up 8.8% year over year.
Another earnings driver, card member loans, is likely to grow in the third quarter, as the company continued to expand its lending relationship with existing and acquired new Card Members, including the acquisitions from Citibank and a portion of Hilton co-brand portfolio. Total loans increased by 14% in the first half of 2018 and the trend is expected to continue sin the third quarter. (Read more:Will Revenue Growth Aid American Express Q3 Earnings?)
American Express carries a Zacks Rank #2 (Buy). Other stock poised to beat earnings estimates in the third quarter because of their favorable Zacks rank and a positive Earnings ESP are Discover Financial Services (DFS - Free Report) , Synchrony Financial (SYF - Free Report) . While Visa Inc. (V - Free Report) also looks to beat earnings but will report its fiscal fourth quarter on Oct 24.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Will Growth in Billed Business Aid AmEx (AXP) Q3 Earnings?
American Express Co. (AXP - Free Report) third-quarter 2018 results are anticipated to witness an increase in worldwide billed business across its diverse customer segments and geographies. Billed business includes activities (including cash advances) related to proprietary cards, cards issued under network partnership agreements (non-proprietary billed business), corporate payments and certain insurance fees charged on proprietary cards.
Card billed business is categorized under the United States or outside the United States based on where the Card Member is domiciled.
U.S. proprietary consumer and international proprietary consumer billings growth are likely to remain strong. the company’s U.S Platinum franchise is anticipated to drive growth in billed business.
Global Network Services billed business is expected to grow at a slower rate over the year than the proprietary business owing to the impact of the evolving regulatory environment in Europe and Australia.
Within the billed business in the U.S., categories such as proprietary consumer and commercial billed business, travel and expenditure (T&E) and non-T&E billed business, and airline related billed business are anticipated to witness growth.
Outside the U.S. billed business is expected to witness growth in Japan, Asia and Australia, Latin America and Canada, Europe, the Middle East and Africa.
In the first half of 2018, card billed business grew 1% year over year to $580.3 billion. Per the Zacks Consensus Estimate, card billed business revenue is expected to be $296 billion, up 8.8% year over year.
Another earnings driver, card member loans, is likely to grow in the third quarter, as the company continued to expand its lending relationship with existing and acquired new Card Members, including the acquisitions from Citibank and a portion of Hilton co-brand portfolio. Total loans increased by 14% in the first half of 2018 and the trend is expected to continue sin the third quarter. (Read more:Will Revenue Growth Aid American Express Q3 Earnings?)
American Express carries a Zacks Rank #2 (Buy). Other stock poised to beat earnings estimates in the third quarter because of their favorable Zacks rank and a positive Earnings ESP are Discover Financial Services (DFS - Free Report) , Synchrony Financial (SYF - Free Report) . While Visa Inc. (V - Free Report) also looks to beat earnings but will report its fiscal fourth quarter on Oct 24.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>